Showing results (181-190 of 283) with videos related to
Sort By:
Pageof 29
Applied Clinical Informatics|January 24, 2014
The association between use of a clinical decision support tool and adherence to monitoring for medication-laboratory guidelines in the ambulatory settingB Lau, C L Overby, H S Wirtz, et al.Social Work|February 16, 2024
Anti-Asian Hate's Impact on Asian American Social Workers: Implications for Professional Training and EducationClifford S Bersamira, Sophia B Lau, Yeonjung Jane Lee, et al.Foot and Ankle Surgery : Official Journal of the European Society of Foot and Ankle Surgeons|October 22, 2023
Tourniquet use in ankle arthroscopy: A systematic reviewB Lau, V Kothari, S Trowbridge, et al.Archives of Dermatological Research|January 8, 2025
Evaluating the readability of FDA-approved JAK inhibitor medication guides in dermatologyWilliam C Lau, Charles B Lau, Vinod Nambudiri, et al.Proceedings of the National Academy of Sciences of the United States of America|January 26, 2011
Identification of a brain center whose activity discriminates a choice behavior in zebrafishBilly Y B Lau, Priya Mathur, Georgianna G Gould, et al.Klinische Padiatrie|May 1, 1984
[Intensive combined drug therapy and beta-interferon in the treatment of children with metastasizing neuroblastoma: GPO-NB 79/82 study]F Berthold, P Kaatsch, G Evers, et al.European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
The current contribution of molecular factors to risk estimation in neuroblastoma patientsF Berthold, K Sahin, B Hero, et al.Klinische Padiatrie|July 1, 1992
[Effect of cranial irradiation on rate of recurrence in children with acute myeloid leukemia. Initial results of the AML-BFM-87 study. The AML-BFM Study Group]U Creutzig, J Ritter, P Heyen, et al.Cancer Genetics and Cytogenetics|March 1, 1995
12q13, a new recurrent breakpoint in acute non-lymphoblastic leukemiaM M Seyger, J Ritterbach, U Creutzig, et al.Klinische Padiatrie|July 1, 1990
The role of chemotherapy in the treatment of children with neuroblastoma stage IV: the GPO (German Pediatric Oncology Society) experienceF Berthold, S Burdach, B Kremens, et al.Pageof 29